| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 11.117 | 20.367 | - | 22.093 | 25.444 | 47.097 | 23.973 | 17.724 | 14.697 | 23.007 |
| Total Income - EUR | 11.144 | 20.367 | - | 22.093 | 25.444 | 47.097 | 96.748 | 76.530 | 63.216 | 157.162 |
| Total Expenses - EUR | 7.693 | 12.134 | - | 10.655 | 22.861 | 41.903 | 90.230 | 70.065 | 23.229 | 42.017 |
| Gross Profit/Loss - EUR | 3.450 | 8.233 | - | 11.439 | 2.583 | 5.194 | 6.519 | 6.465 | 39.987 | 115.145 |
| Net Profit/Loss - EUR | 3.116 | 7.732 | - | 11.224 | 2.329 | 4.723 | 5.668 | 5.814 | 39.450 | 111.514 |
| Employees | 1 | 1 | - | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Bioterravet Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.397 | 1.090 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 19.421 | 27.276 | - | 46.266 | 46.851 | 51.666 | 108.239 | 254.248 | 102.359 | 129.929 |
| Inventories | 5.662 | 3.149 | - | 2.422 | 7.926 | 7.280 | 3.045 | 7.703 | 6.628 | 0 |
| Receivables | 104 | 4.126 | - | 18.272 | 14.412 | 36.064 | 103.097 | 235.721 | 5.779 | 67.993 |
| Cash | 13.655 | 20.001 | - | 25.572 | 24.514 | 8.322 | 2.097 | 10.824 | 89.951 | 61.936 |
| Shareholders Funds | 20.261 | 27.785 | - | 44.840 | 46.301 | 50.146 | 54.702 | 60.686 | 99.952 | 111.597 |
| Social Capital | 45 | 45 | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 557 | 581 | - | 1.426 | 550 | 1.520 | 53.537 | 193.563 | 2.407 | 18.332 |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Bioterravet Srl